BGNE

equitynet selling

BeOne Medicines AG · SHANGHAI STOCK EXCHANGE

View price on Yahoo Finance ↗
Disclosed trades
2
0 buys · 2 sells
Members involved
1
Estimated volume
$16K
sum of ranges
Most recent
Jul 12, 2023
since Jul 10, 2023

Buy it with play money

Fills at the latest stored close and lands in your paper portfolio

Sign in to buy BGNE with $10,000 of play money and watch it from here.

Sign in to trade

Price, and when Congress traded it

Hollow marks where they traded, filled where the filing went public

BGNE closing price, with each disclosed trade marked at the date it happened and the date it was filed$171$201$231Oct 24Nov 24Dec 24
they tradedyou found outthe delaygreen buys · red sells

Hover a marker to see who traded and what it was worth.

If you had bought it yourself

Paid at that day's close, held ever since. No member involved.

Amount
Latest stored close.

Working it out…

Short interest

Shares sold short, as brokers report them to FINRA twice a month

Shares short
1.31M
at Dec 31, 2024
Of shares outstanding
—
Days to cover
4.4
Since the last report
-4.6%
from 1.38M at Dec 13, 2024
Oct 15, 2024: 1.51M shares shortOct 31, 2024: 1.09M shares shortNov 15, 2024: 999.4K shares shortNov 29, 2024: 1.33M shares shortDec 13, 2024: 1.38M shares shortDec 31, 2024: 1.31M shares short
Oct 15, 2024Dec 31, 2024
Settlement dateShares shortChangeDays to cover
Dec 31, 20241.31M-4.6%4.4
Dec 13, 20241.38M+3.3%2.2
Nov 29, 20241.33M+33.2%4.6
Nov 15, 2024999.4K-8.2%3.4
Oct 31, 20241.09M-27.9%3.9
Oct 15, 20241.51M—3.4

Short interest is every broker's short position at the settlement date, reported to FINRA and published about a week and a half later; it does not say who is short. Days to cover is the short position over the average day's trading, and the share of the company is against the shares outstanding on its latest filing. A fail to deliver is the balance of shares sold and not delivered by settlement, from the SEC: it can be a short seller who never borrowed the stock, but is as often a late delivery that clears within days.

What they lobby on

Disclosed to the Senate, largest spend first

  • BEONE MEDICINES USA, INC. (FORMERLY BEIGENE USA, INC.)$350K

    Health Issues

    2nd Quarter (Apr 1 - June 30) 2026

  • BEONE MEDICINES USA, INC. (FORMERLY BEIGENE USA, INC.)$250K

    Health Issues

    1st Quarter (Jan 1 - Mar 31) 2026

  • WILLIAMS AND JENSEN, PLLC$80K

    Health Issues, Trade (domestic/foreign), Medicare/Medicaid, Manufacturing, Pharmacy

    1st Quarter (Jan 1 - Mar 31) 2026

  • WILLIAMS AND JENSEN, PLLC$80K

    Health Issues, Trade (domestic/foreign), Medicare/Medicaid, Manufacturing, Pharmacy

    2nd Quarter (Apr 1 - June 30) 2026

  • TIBER CREEK GROUP$70K

    Health Issues, Medicare/Medicaid, Budget/Appropriations

    1st Quarter (Jan 1 - Mar 31) 2026

  • TIBER CREEK GROUP$70K

    Health Issues, Medicare/Medicaid

    2nd Quarter (Apr 1 - June 30) 2026

  • B HALL STRATEGIES, LLC$30K

    Pharmacy

    2nd Quarter (Apr 1 - June 30) 2026

  • B HALL STRATEGIES, LLC$30K

    Pharmacy

    1st Quarter (Jan 1 - Mar 31) 2026

More on BGNE

Who traded it

Most active first

MemberBuysSells
Dan GoldmanNY-10 · house—2

Every disclosure

2 in total, newest first

MemberAmount
Dan GoldmanNY · housesell$1K – $15K
Dan GoldmanNY · housesell$1K – $15K

Follow BeOne Medicines AG (BGNE) by email

New trades in BeOne Medicines AG (BGNE) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.